28 May 2025
Association between obesity biomarkers and breast cancer risk in Nigeria.Publisher siteJournal of Clinical Oncology, Cancer Risks and Factors
Active, last published 2026
In prostate cancer diagnosis and treatment
Emeka
Nnakenyi
Scholar“Research focused on Prostate Cancer Diagnosis and Treatment and adjacent fields.”
Claim Your Profile2
H-index
9
Citations
Emeka has not officially claimed their profile. If you are Emeka, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
meka Nnakenyi is a researcher working on Prostate Cancer Diagnosis and Treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Emeka's work has been cited 9 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Prostate Cancer Diagnosis and Treatment×2Sarcoma Diagnosis and Treatment×2Prostate Cancer Treatment and Research×2Testicular diseases and treatments×2
04 · Where I am
Affiliations
Affiliation on published researchUniversity of Nigeria Teaching Hospital, NigeriaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works1 Apr 2025Open access
Clinicopathologic Profile and Pelvic Magnetic Resonance Imaging Pattern of Prostate Cancer in Southeast NigeriaPublisher siteNigerian Journal of Clinical Practice, Prostate Cancer Diagnosis and Treatment
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Emeka?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you